|
Mechanismβ-adrenoceptors antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with SaJo Consulting UG
0 Patents (Medical) associated with SaJo Consulting UG
100 Deals associated with SaJo Consulting UG
100 Translational Medicine associated with SaJo Consulting UG